Incidence of Suspected Serious Adverse Drug Reactions in Corona Virus Disease-19 Patients Detected by a Pharmacovigilance Program by Laboratory Signals in a Tertiary Hospital in Spain: Cautionary Data

BACKGROUND: From March to April 2020, Spain was the center of the SARS-CoV-2 pandemic, particularly Madrid with approximately 30% of the cases in Spain. The aim of this study is to report the suspected serious adverse drug reactions (SADRs) in COVID-19 patients vs. non-COVID-19 patients detected by...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Pharmacol
Autors principals: Ramírez, Elena, Urroz, Mikel, Rodríguez, Amelia, González-Muñoz, Miguel, Martín-Vega, Alberto, Villán, Yuri, Seco, Enrique, Monserrat, Jaime, Frías, Jesús, Carcas, Antonio J., Borobia, Alberto M.
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2020
Matèries:
Pharmacology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7744878/
https://ncbi.nlm.nih.gov/pubmed/33343374
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.602841
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars